分享好友 资讯首页 频道列表

AB InBev Reports First Quarter 2025 Results

2025-05-09 10:3214840

Solid start to the year with EBITDA growth at the top-end of our outlook, continued margin expansion and high-single digit Underlying EPS growth

BRUSSELS--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):

Regulated information1

“Beer is a passion point for consumers. The strength of the beer category and the continued momentum of our megabrands delivered another quarter of profitable growth. EBITDA increased at the top-end of our outlook and the ongoing optimization of our business drove Underlying EPS growth of 7.1%. The consistent execution of our strategy by our teams and partners drove a solid start to the year and reinforces our confidence in delivering on our outlook for 2025.” – Michel Doukeris, CEO, AB InBev

Revenue

+1.5%

Revenue increased by 1.5% with revenue per hl growth of 3.7%. Reported revenue decreased by 6.3% to 13 628 million USD, impacted by unfavorable currency translation.

 

4.4% increase in combined revenues of our megabrands, led by Corona, which grew by 11.2% outside of its home market in 1Q25.

 

34% increase in revenue of our no-alcohol beer portfolio.

 

53% increase in Gross Merchandise Value (GMV) from sales of third-party products through BEES Marketplace to reach 645 million USD.

 

Volumes

-2.2%

Volumes declined by 2.2%, with beer volumes down by 2.5% and non-beer volumes down by 0.2%.

Normalized EBITDA

+7.9%

In 1Q25, Normalized EBITDA increased by 7.9% to 4 855 million USD with a margin expansion of 218bps to 35.6%.

 

Underlying Profit

1 606 million USD

Underlying Profit was 1 606 million USD in 1Q25 compared to 1 509 million USD in 1Q24. Reported profit attributable to equity holders of AB InBev was 2 148 million USD in 1Q25 compared to 1 091 million USD in 1Q24, positively impacted by non-underlying items.

 

Underlying EPS

0.81 USD

Underlying EPS increased by 7.1% to 0.81 USD. On a constant currency basis, Underlying EPS increased by 20.2%.

1The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market. For important disclaimers and notes on the basis of preparation, please refer to page 12.

Management comments

Solid start to the year with EBITDA growth at the top-end of our outlook, continued margin expansion and high-single digit Underlying EPS growth

Our business delivered another quarter of solid financial performance in 1Q25. EBITDA increased by 7.9% with margin expansion of 218bps driven by top-line growth, cost of sales tailwinds and disciplined overhead management. Underlying EPS was 0.81 USD, a 7.1% increase in USD and a 20.2% increase in constant currency versus 1Q24, driven by 10.3% EBIT growth and the continued optimization of our net finance costs.

Top-line increased by 1.5%, with revenue growth in approximately 50% of our markets, driven by a revenue per hl increase of 3.7% as a result of disciplined revenue management choices and ongoing premiumization. We increased our overall portfolio brand power driven by increased marketing investment and effectiveness. In addition, we estimate that we gained or maintained market share in 60% of our markets. Volume performance was, however, impacted by calendar-related factors such as cycling the leap year selling-day benefit in 1Q24 and Easter shipment phasing, resulting in a decline of 2.2%.

Progressing our strategic priorities

We continue to execute on and invest in three key strategic pillars to deliver consistent growth and long-term value creation.

(1) Lead and grow the category:

We increased our overall portfolio brand power driven by increased marketing investment and effectiveness. In addition, we estimate that we gained or maintained market share in 60% of our markets.

(2) Digitize and monetize our ecosystem:

BEES Marketplace captured 645 million USD in GMV from sales of third-party products, a 53% increase versus 1Q24. Overall BEES GMV increased by 10%, reaching 11.6 billion USD.

(3) Optimize our business:

Underlying EPS was 0.81 USD, a 7.1% increase in USD and a 20.2% increase in constant currency terms versus 1Q24, driven by 10.3% EBIT growth and the continued optimization of our net finance costs.

(1) Lead and grow the category

We are executing on our five replicable levers to drive category growth. Our performance across each of the levers was led by our megabrands which delivered a 4.4% revenue increase.

(2) Digitize and monetize our ecosystem

(3) Optimize our business

Delivering reliable compounding growth

We are encouraged by our results to start the year, the resilience of the beer category and the consistent execution of our strategy by our teams and partners. Our business is local, with more than 98% of our volume locally produced, and our footprint has structural tailwinds for long-term volume growth with favorable demographics, ongoing economic development and opportunities to increase category participation. Our consistent performance and the fundamental strengths of our business reinforce our confidence in our ability to deliver reliable compounding growth and create a future with more cheers.

2025 Outlook

(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY25 reflects our current assessment of inflation and other macroeconomic conditions.

(ii) Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 190 to 220 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY25 to be approximately 4%.

(iii) Effective Tax Rate (ETR): We expect the normalized ETR in FY25 to be in the range of 26% to 28%. The ETR outlook does not consider the impact of potential future changes in legislation.

(iv) Net Capital Expenditure: We expect net capital expenditure of between 3.5 and 4.0 billion USD in FY25.

Figure 1. Consolidated performance

           

in USD Mio, except EPS in USD per share and Volumes in thousand hls

 

1Q24

 

1Q25

 

Organic

           

growth

Volumes

 

139 536

 

136 268

 

(2.2

)%

Beer

 

119 683

 

116 778

 

(2.5

)%

Non-Beer

 

19 852

 

19 490

 

(0.2

)%

Revenue

 

14 547

 

13 628

 

1.5

%

Gross profit

 

7 894

 

7 583

 

5.2

%

Gross margin

 

54.3%

 

55.6%

 

203bps

Normalized EBITDA

 

4 987

 

4 855

 

7.9

%

Normalized EBITDA margin

 

34.3%

 

35.6%

 

218bps

Normalized EBIT

 

3 642

 

3 587

 

10.3

%

Normalized EBIT margin

 

25.0%

 

26.3%

 

218bps

 

           

Profit attributable to equity holders of AB InBev

 

1 091

 

2 148

   

Underlying Profit

 

1 509

 

1 606

   

 

           

Basic EPS

 

0.54

 

1.08

   

Underlying EPS

 

0.75

 

0.81

 

 

Figure 2. Volumes

                       

in thousand hls

 

1Q24

 

Scope

 

Organic

growth

 

1Q25

 

Organic growth

                 

Total

 

Beer

North America

 

21 353

 

(144

)

 

(1 368

)

 

19 842

 

(6.4

)%

 

(6.4

)%

Middle Americas

 

35 690

 

-

 

 

(610

)

 

35 081

 

(1.7

)%

 

(1.5

)%

South America

 

40 347

 

-

 

 

544

 

 

40 891

 

1.3

%

 

1.4

%

EMEA

 

21 030

 

(35

)

 

(243

)

 

20 752

 

(1.2

)%

 

(1.8

)%

Asia Pacific

 

21 045

 

(93

)

 

(1 304

)

 

19 648

 

(6.2

)%

 

(6.2

)%

Global Export and Holding Companies

 

70

 

(3

)

 

(13

)

 

54

 

(19.2

)%

 

(19.2

)%

AB InBev Worldwide

 

139 536

 

(274

)

 

(2 993

)

 

136 268

 

(2.2

)%

 

(2.5

)%

Key Markets Performance

United States: Michelob Ultra growth drove continued market share gain

Mexico: Revenue growth and margin expansion drove double-digit bottom-line growth

Colombia: Record high volumes drove double-digit bottom-line growth

Brazil: Continued momentum drove double-digit bottom-line growth with margin expansion and all-time high volumes

Europe: Continued premiumization and margin recovery drove double-digit bottom-line growth

South Africa: Continued momentum and market share gain delivered another quarter of top- and bottom-line growth

China: Performance impacted by soft industry in our footprint

Highlights from our other markets

Consolidated Income Statement

Figure 3. Consolidated income statement

           

in USD Mio

 

1Q24

 

1Q25

 

Organic

           

growth

Revenue

 

14 547

 

 

13 628

 

 

1.5

%

Cost of sales

 

(6 653

)

 

(6 044

)

 

3.1

%

Gross profit

 

7 894

 

 

7 583

 

 

5.2

%

SG&A

 

(4 435

)

 

(4 188

)

 

(1.3

)%

Other operating income/(expenses)

 

183

 

 

192

 

 

9.1

%

Normalized EBIT

 

3 642

 

 

3 587

 

 

10.3

%

Non-underlying items above EBIT

 

(29

)

 

(49

)

   

Net finance income/(cost)

 

(1 187

)

 

(984

)

   

Non-underlying net finance income/(cost)

 

(309

)

 

602

 

   

Share of results of associates

 

57

 

 

52

 

   

Non-underlying share of results of associates

 

104

 

 

-

 

   

Income tax expense

 

(794

)

 

(664

)

   

Profit

 

1 485

 

 

2 544

 

   

Profit attributable to non-controlling interest

 

393

 

 

396

 

   

Profit attributable to equity holders of AB InBev

 

1 091

 

 

2 148

 

   
             

Normalized EBITDA

 

4 987

 

 

4 855

 

 

7.9

%

Underlying Profit

 

1 509

 

 

1 606

 

 

 

Non-underlying items above EBIT & Non-underlying share of results of associates

Figure 4. Non-underlying items above EBIT & Non-underlying share of results of associates

       

in USD Mio

 

1Q24

 

1Q25

Restructuring

 

(31

)

 

(12

)

Business and asset disposal (incl. impairment losses)

 

2

 

 

(37

)

Non-underlying items in EBIT

 

(29

)

 

(49

)

Non-underlying share of results of associates

 

104

 

 

-

 

Normalized EBIT excludes negative non-underlying items of 49 million USD in 1Q25 and 29 million USD in 1Q24. Non-underlying share of results from associates of 1Q24 included the impact from our associate Anadolu Efes’ adoption of IAS 29 hyperinflation accounting on their 2023 results.

Net finance income/(cost)

Figure 5. Net finance income/(cost)

       

in USD Mio

 

1Q24

 

1Q25

Net interest expense

 

(714

)

 

(651

)

Net interest on net defined benefit liabilities

 

(22

)

 

(18

)

Accretion expense

 

(191

)

 

(149

)

Net interest income on Brazilian tax credits

 

36

 

 

30

 

Other financial results

 

(296

)

 

(196

)

Net finance income/(cost)

 

(1 187

)

 

(984

)

Non-underlying net finance income/(cost)

Figure 6. Non-underlying net finance income/(cost)

       

in USD Mio

 

1Q24

 

1Q25

Mark-to-market

 

(243

)

 

602

Gain/(loss) on bond redemption and other

 

(66

)

 

-

Non-underlying net finance income/(cost)

 

(309

)

 

602

Non-underlying net finance cost in 1Q25 includes mark-to-market gains on derivative instruments entered into in order to hedge our share-based payment programs and shares issued in relation to the combination with Grupo Modelo and SAB.

The number of shares covered by the hedging of our share-based payment program, the deferred share instrument and the restricted shares are shown below, together with the opening and closing share prices.

Figure 7. Non-underlying equity derivative instruments

       
   

1Q24

 

1Q25

Share price at the start of the period (Euro)

 

58.42

 

48.25

Share price at the end of the period (Euro)

 

56.46

 

56.92

Number of equity derivative instruments at the end of the period (millions)

 

100.5

 

100.5

Income tax expense

Figure 8. Income tax expense

       

in USD Mio

 

1Q24

 

1Q25

Income tax expense

 

794

 

664

Effective tax rate

 

37.5%

 

21.0%

Normalized effective tax rate

 

27.0%

 

25.9%

The 1Q25 effective tax rate was positively impacted by non-taxable gains from derivatives related to the hedging of share-based payment programs and of the shares issued in a transaction related to the combination with Grupo Modelo and SAB, while the 1Q24 effective tax rate was negatively impacted by non-deductible losses from these derivatives.

Furthermore, the 1Q24 effective tax rate includes 240 million USD (4.5 billion ZAR) non-underlying tax cost following the resolution in 1Q24 of the South African tax matters described in note 29 Contingencies of the 2024 Consolidated Financial Statements.

The decrease in Normalized ETR in 1Q25 compared to 1Q24 is driven mainly by country mix.

Underlying EPS

Figure 9. Underlying EPS

       

in USD per share, except number of shares in million

 

1Q24

 

1Q25

Normalized EBITDA

 

2.48

 

 

2.43

 

Depreciation, amortization and impairment

 

(0.67

)

 

(0.64

)

Normalized EBIT

 

1.81

 

 

1.80

 

Net finance income/(cost)

 

(0.59

)

 

(0.49

)

Income tax expense

 

(0.33

)

 

(0.34

)

Associates & non-controlling interests

 

(0.17

)

 

(0.17

)

Hyperinflation impacts

 

0.03

 

 

0.01

 

Underlying EPS

 

0.75

 

 

0.81

 

Weighted average number of ordinary and restricted shares

 

2 007

 

 

1 994

 

Reconciliation of IFRS and Non-IFRS Financial Measures

Profit attributable to equity holders and Underlying Profit

Figure 10. Underlying Profit

       

in USD Mio

 

1Q24

 

1Q25

Profit attributable to equity holders of AB InBev

 

1 091

 

2 148

 

Net impact of non-underlying items on profit

 

362

 

(565

)

Hyperinflation impacts

 

55

 

23

 

Underlying Profit

 

1 509

 

1 606

 

Basic and Underlying EPS

Figure 11. Basic and Underlying EPS

       

in USD per share, except number of shares in million

 

1Q24

 

1Q25

Basic EPS

 

0.54

 

1.08

 

Net impact of non-underlying items

 

0.18

 

(0.28

)

Hyperinflation impacts

 

0.03

 

0.01

 

Underlying EPS

 

0.75

 

0.81

 

FX translation impact

 

-

 

0.09

 

Underlying EPS in constant currency

 

0.75

 

0.90

 

Weighted average number of ordinary and restricted shares

 

2 007

 

1 994

 

Profit attributable to equity holders and Normalized EBITDA

Figure 12. Reconciliation of Normalized EBITDA to Profit attributable to equity holders of AB InBev

       

in USD Mio

 

1Q24

 

1Q25

Profit attributable to equity holders of AB InBev

 

1 091

 

 

2 148

 

Non-controlling interests

 

393

 

 

396

 

Profit

 

1 485

 

 

2 544

 

Income tax expense

 

794

 

 

664

 

Share of result of associates

 

(57

)

 

(52

)

Non-underlying share of results of associates

 

(104

)

 

-

 

Net finance (income)/cost

 

1 187

 

 

984

 

Non-underlying net finance (income)/cost

 

309

 

 

(602

)

Non-underlying items above EBIT (incl. impairment losses)

 

29

 

 

49

 

Normalized EBIT

 

3 642

 

 

3 587

 

Depreciation, amortization and impairment

 

1 344

 

 

1 268

 

Normalized EBITDA

 

4 987

 

 

4 855

 

Normalized EBITDA, Normalized EBIT and Underlying Profit are non-IFRS financial measures used by AB InBev to reflect the company’s underlying performance. Underlying EPS and constant currency Underlying EPS are non-IFRS financial measures that AB InBev believes are useful to investors because they facilitate comparisons of EPS from period to period.

Normalized EBITDA is calculated by adjusting profit attributable to equity holders of AB InBev to exclude: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) non-underlying share of results of associates; (v) net finance income or cost; (vi) non-underlying net finance income or cost; (vii) non-underlying items above EBIT; and (viii) depreciation, amortization and impairment.

Underlying Profit is calculated by adjusting profit attributable to equity holders of AB InBev to exclude: (i) non-underlying items and (ii) hyperinflation impacts. Underlying EPS is calculated as Underlying Profit divided by the weighted average number of ordinary and restricted shares. Constant currency Underlying EPS is calculated as Underlying EPS excluding the effects of foreign currency translation by translating current period figures using the exchange rates from the same period in the prior year.

Normalized EBITDA, Normalized EBIT and Underlying Profit are not accounting measures under IFRS and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Underlying EPS and constant currency Underlying EPS are not accounting measures under IFRS and should not be considered as alternatives to earnings per share as a measure of operating performance on a per share basis. These non-IFRS financial measures do not have a standard calculation method and AB InBev’s definition of Normalized EBITDA, Normalized EBIT, Underlying Profit, Underlying EPS and constant currency Underlying EPS may not be comparable to that of other companies.

Notes

To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Since 1Q24, the definition of organic revenue growth has been amended to cap the price growth in Argentina to a maximum of 2% per month (26.8% year-over-year). Corresponding adjustments are made to all income statement related items in the organic growth calculations through scope changes. Scope changes also represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. The organic growth of our global brands, Budweiser, Stella Artois, and Corona excludes exports to Australia for which a perpetual license was granted to a third party upon disposal of the Australia operations in 2020. All references per hectoliter (per hl) exclude US non-beverage activities. Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a “normalized” basis, which means they are presented before non-underlying items. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the Company’s performance. We are reporting the results from Argentina applying hyperinflation accounting since 3Q18. The IFRS rules (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. In 1Q25, we reported a negative impact from hyperinflation accounting on the profit attributable to equity holders of AB InBev of (23) million USD. The impact in 1Q25 Basic EPS was (0.01) USD. Values in the figures and annexes may not add up, due to rounding. 1Q25 EPS is based upon a weighted average of 1 994 million shares compared to a weighted average of 2 007 million shares for 1Q24.

Legal disclaimer

This release contains “forward-looking statements”. These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “ambition”, “estimates”, “likely”, “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including, but not limited to the risks and uncertainties relating to AB InBev that are described under Item 3.D of AB InBev’s Annual Report on Form 20-F filed with the SEC on 12 March 2025. Many of these risks and uncertainties are, and will be, exacerbated by any further worsening of the global business and economic environment, including as a result of foreign currency exchange rate fluctuations and ongoing geopolitical conflicts. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The first quarter 2025 (1Q25) financial data set out in Figure 1 (except for the volume information), Figures 3 to 6, 8, 11 and 12 of this press release have been extracted from the group’s unaudited condensed consolidated interim financial statements as of and for the three months ended 31 March 2025, which have been reviewed by our statutory auditors PwC Réviseurs d’Entreprises SRL / PwC Bedrijfsrevisoren BV in accordance with the standards of the Public Company Accounting Oversight Board (United States). Financial data included in Figures 7, 9 and 11 have been extracted from the underlying accounting records as of and for the three months ended 31 March 2025. References in this document to materials on our websites, such as www.ab-inbev.com, are included as an aid to their location and are not incorporated by reference into this document.

Conference call and webcast

Investor Conference call and webcast on Thursday, 8 May 2025:
3.00pm Brussels / 2.00pm London / 9.00am New York

Registration details:
Webcast (listen-only mode):
AB InBev 1Q25 Results Webcast

To join by phone, please use one of the following two phone numbers:
Toll-Free: +1-877-407-8029
Toll: +1-201-689-8029

About AB InBev

Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 144 000 colleagues based in nearly 50 countries worldwide. For 2024, AB InBev’s reported revenue was 59.8 billion USD (excluding JVs and associates).

Annex 1: Segment reporting

AB InBev Worldwide

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

Organic

Growth

Volumes

 

139 536

 

 

(274

)

 

-

 

 

(2 993

)

 

136 268

 

 

(2.2

)%

Revenue

 

14 547

 

 

(31

)

 

(1 099

)

 

210

 

 

13 628

 

 

1.5

%

Cost of sales

 

(6 653

)

 

(64

)

 

471

 

 

202

 

 

(6 044

)

 

3.1

%

Gross profit

 

7 894

 

 

(96

)

 

(627

)

 

412

 

 

7 583

 

 

5.2

%

SG&A

 

(4 435

)

 

(20

)

 

324

 

 

(57

)

 

(4 188

)

 

(1.3

)%

Other operating income/(expenses)

 

183

 

 

14

 

 

(21

)

 

17

 

 

192

 

 

9.1

%

Normalized EBIT

 

3 642

 

 

(103

)

 

(324

)

 

372

 

 

3 587

 

 

10.3

%

Normalized EBITDA

 

4 987

 

 

(100

)

 

(424

)

 

392

 

 

4 855

 

 

7.9

%

Normalized EBITDA margin

 

34.3

%

             

35.6

%

 

218bps

 

                       

North America

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

Organic

Growth

Volumes

 

21 353

 

 

(144

)

 

-

 

 

(1 368

)

 

19 842

 

 

(6.4

)%

Revenue

 

3 593

 

 

(36

)

 

(25

)

 

(168

)

 

3 364

 

 

(4.7

)%

Cost of sales

 

(1 544

)

 

20

 

 

9

 

 

106

 

 

(1 410

)

 

7.0

%

Gross profit

 

2 049

 

 

(16

)

 

(17

)

 

(62

)

 

1 953

 

 

(3.0

)%

SG&A

 

(1 085

)

 

(6

)

 

11

 

 

29

 

 

(1 052

)

 

2.7

%

Other operating income/(expenses)

 

(12

)

 

-

 

 

1

 

 

25

 

 

14

 

 

207.0

%

Normalized EBIT

 

951

 

 

(22

)

 

(5

)

 

(8

)

 

916

 

 

(0.8

)%

Normalized EBITDA

 

1 126

 

 

(22

)

 

(7

)

 

(10

)

 

1 087

 

 

(0.9

)%

Normalized EBITDA margin

 

31.3

%

             

32.3

%

 

125bps

 

                       

Middle Americas

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

Organic

Growth

Volumes

 

35 690

 

 

-

 

 

-

 

 

(610

)

 

35 081

 

 

(1.7

)%

Revenue

 

4 051

 

 

(12

)

 

(400

)

 

144

 

 

3 784

 

 

3.6

%

Cost of sales

 

(1 586

)

 

(14

)

 

138

 

 

113

 

 

(1 350

)

 

7.1

%

Gross profit

 

2 465

 

 

(26

)

 

(262

)

 

257

 

 

2 434

 

 

10.5

%

SG&A

 

(965

)

 

6

 

 

101

 

 

(53

)

 

(911

)

 

(5.5

)%

Other operating income/(expenses)

 

12

 

 

-

 

 

(2

)

 

1

 

 

12

 

 

7.2

%

Normalized EBIT

 

1 512

 

 

(20

)

 

(162

)

 

204

 

 

1 535

 

 

13.6

%

Normalized EBITDA

 

1 886

 

 

(20

)

 

(201

)

 

192

 

 

1 858

 

 

10.3

%

Normalized EBITDA margin

 

46.6

%

             

49.1

%

 

300bps

                         

South America

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

 

Organic

Growth

Volumes

 

40 347

 

 

-

 

 

-

 

 

544

 

 

40 891

 

 

1.3

%

Revenue

 

3 233

 

 

45

 

 

(576

)

 

276

 

 

2 978

 

 

8.5

%

Cost of sales

 

(1 586

)

 

(89

)

 

281

 

 

(56

)

 

(1 450

)

 

(3.5

)%

Gross profit

 

1 647

 

 

(43

)

 

(295

)

 

220

 

 

1 528

 

 

13.4

%

SG&A

 

(941

)

 

(33

)

 

168

 

 

(43

)

 

(849

)

 

(4.6

)%

Other operating income/(expenses)

 

116

 

 

8

 

 

(18

)

 

(9

)

 

97

 

 

(7.8

)%

Normalized EBIT

 

821

 

 

(68

)

 

(145

)

 

168

 

 

776

 

 

20.9

%

Normalized EBITDA

 

1 084

 

 

(65

)

 

(192

)

 

180

 

 

1 007

 

 

16.8

%

Normalized EBITDA margin

 

33.5

%

             

33.8

%

 

253bps

EMEA

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

Organic

Growth

Volumes

 

21 030

 

 

(35

)

 

-

 

 

(243

)

 

20 752

 

 

(1.2

)%

Revenue

 

1 927

 

 

(8

)

 

(45

)

 

91

 

 

1 965

 

 

4.8

%

Cost of sales

 

(1 036

)

 

10

 

 

26

 

 

(29

)

 

(1 028

)

 

(2.8

)%

Gross profit

 

892

 

 

2

 

 

(18

)

 

62

 

 

937

 

 

7.0

%

SG&A

 

(614

)

 

(16

)

 

16

 

 

7

 

 

(607

)

 

1.1

%

Other operating income/(expenses)

 

44

 

 

5

 

 

(2

)

 

(4

)

 

44

 

 

(7.4

)%

Normalized EBIT

 

322

 

 

(8

)

 

(4

)

 

65

 

 

375

 

 

20.7

%

Normalized EBITDA

 

569

 

 

(8

)

 

(10

)

 

74

 

 

624

 

 

13.1

%

Normalized EBITDA margin

 

29.5

%

             

31.7

%

 

235bps

 

                       

Asia Pacific

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

Organic

Growth

Volumes

 

21 045

 

 

(93

)

 

-

 

 

(1 304

)

 

19 648

 

 

(6.2

)%

Revenue

 

1 634

 

 

(7

)

 

(52

)

 

(125

)

 

1 450

 

 

(7.7

)%

Cost of sales

 

(763

)

 

(2

)

 

23

 

 

58

 

 

(685

)

 

7.6

%

Gross profit

 

871

 

 

(9

)

 

(30

)

 

(67

)

 

766

 

 

(7.8

)%

SG&A

 

(445

)

 

(3

)

 

16

 

 

11

 

 

(420

)

 

2.5

%

Other operating income/(expenses)

 

26

 

 

-

 

 

-

 

 

(1

)

 

24

 

 

(4.7

)%

Normalized EBIT

 

452

 

 

(12

)

 

(13

)

 

(57

)

 

369

 

 

(12.9

)%

Normalized EBITDA

 

616

 

 

(11

)

 

(18

)

 

(63

)

 

523

 

 

(10.4

)%

Normalized EBITDA margin

 

37.7

%

             

36.1

%

 

(112)bps

 

                       

Global Export and Holding Companies

 

1Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

1Q25

 

Organic

Growth

Volumes

 

70

 

 

(3

)

 

-

 

 

(13

)

 

54

 

 

(19.2

)%

Revenue

 

109

 

 

(14

)

 

(1

)

 

(8

)

 

86

 

 

(8.6

)%

Cost of sales

 

(138

)

 

11

 

 

(5

)

 

10

 

 

(122

)

 

8.2

%

Gross profit

 

(29

)

 

(3

)

 

(6

)

 

2

 

 

(36

)

 

7.0

%

SG&A

 

(385

)

 

31

 

 

12

 

 

(7

)

 

(349

)

 

(2.1

)%

Other operating income/(expenses)

 

(3

)

 

-

 

 

-

 

 

4

 

 

1

 

 

118.8

%

Normalized EBIT

 

(417

)

 

28

 

 

6

 

 

(1

)

 

(384

)

 

(0.2

)%

Normalized EBITDA

 

(295

)

 

28

 

 

4

 

 

20

 

 

(244

)

 

7.4

%

 

Contacts

Investors
Shaun Fullalove
E-mail: shaun.fullalove@ab-inbev.com

Ekaterina Baillie
E-mail: ekaterina.baillie@ab-inbev.com

Cyrus Nentin
E-mail: cyrus.nentin@ab-inbev.com

Media
Media Relations
E-mail: media.relations@ab-inbev.com

 

AB InBev Strategic Priorities

反对 0
举报 0
收藏 0
打赏 0
评论 0
Cirium(睿思誉)发布业内首款AI驱动航班准点率分析解决方案
伦敦--(美国商业资讯)--全球领先的航空数据分析公司Cirium(睿思誉)推出了OTP Improvement AI,这是一款开创性生成式AI创新解决方案,致力于革新航空公司和机场分析,并提升准点率(OTP)。OTP Improvement AI这一创新工具能够应对运营效率和航班中断管理领域的长期挑战,提供更快、更智能且更具前瞻性的决策能力。 OTP Improvement AI专注于解决航空公司和机场面临的具体问题,如传统OTP分析耗时费力,以及难以有效管理因天气或技术故障等因素引起...

0评论2025-07-011505

IFF 發佈《2024 Do More Good Report》彰顯可持續發展與創新成果
公司繼續提供可持續解決方案,協助客戶與消費者在 2024 年減少 2,730 萬公噸二氧化碳當量排放。 紐約--(美國商業資訊)-- IFF(紐交所代碼:IFF)是全球香精香料、食品配料、健康和生物科學領域的領導者,現已發佈其 2024 Do More Good Report。報告展示了該公司在可持續發展、變革性創新及對人類和地球承諾方面的年度成果,並透過四大核心支柱,強調 IFF 可持續解決方案的影響,圍繞全新主題「可能的科學」,包括:有意識的採購、有目的的創新、有影響力的合作,以及面...

0评论2025-07-011092

CB Insights發布業界首個AI代理工作團隊,用於併購、合作夥伴關係、競爭情報、交易來源、上市策略等用途
專用代理全天候運作,提供外部情報,改變企業制定策略決策的方式 紐約--(美國商業資訊)--預測型市場情報的領導供應商CB Insights今日宣布推出其「代理團隊」,這是業界首個專為企業領導人打造的全面性AI代理工作團隊,旨在提供隨時可用的市場情報以協助策略決策。CB Insights持續擴展中的代理團隊起初由11位專門的代理組成,這些代理持續運作,發掘洞察、將專有資料轉化為行動,並透過提供企業為了在業務拓展、投資、合作夥伴、GTM以及競爭情報等領域中有效競爭所需的外部情報層,加速明智決策。 ...

0评论2025-07-011924

Gigaphoton将九州地区现场服务能力提升至三倍
九州办事处竣工,强化现场服务运营 日本小山--(美国商业资讯)--半导体光刻光源制造商Gigaphoton Inc.(总部:枥木县小山;总裁兼首席执行官:Tatsuo Enami)宣布,其九州办事处于6月27日正式竣工,服务能力显著提升至原来的三倍。 自2000年设立初始支持办事处以来,Gigaphoton一直为九州地区的客户提供服务。为应对九州地区近期的投资热潮,以及客户将进一步加大投资的趋势,该公司已强化其服务能力。 新的九州办事处是Gigaphoton除小山总部外,在日本国内拥有...

0评论2025-07-011215

Kinaxis与渥太华参议员队续约合作,携手共促首都地区发展
重磅合作聚焦提升社区影响力与品牌价值 安大略省渥太华--(美国商业资讯)--端到端供应链协调全球领导企业Kinaxis®(TSX:KXS)欣然宣布与渥太华参议员队及其AHL附属球队贝尔维尔参议员队续签三年合作伙伴关系。此次合作将提升Kinaxis品牌曝光度,深化社区联结,并为客户、潜在合作伙伴及员工创造难忘体验。 作为渥太华两大本土标杆机构,Kinaxis与参议员队将再度强强联手,礼赞本土英才,培育青少年发展并深化社区参与。同时Kinaxis品牌将借助加拿大轮胎中心(Canadia...

0评论2025-07-011241

Omdia:2025年电视出货量将持平,但Mini LED将以82.9%的增速爆发式增长
伦敦--(美国商业资讯)-- Omdia最新发布的2025年第一季度电视市场预测报告显示,2025年全球电视出货量预计基本持平,总量为2.087亿台(同比下降0.1%)。尽管整体需求温和,但在零售商和品牌聚焦高端功能的推动下,Mini LED技术和超大尺寸显示屏的增长将十分迅猛。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20250626253197/zh-CN/ Omdia最新的电视市场分析强调,2025...

0评论2025-07-011386

Novoloop 获得由 Taranis 领投的2100万美元B轮融资,加速循环高性能材料规模化
加利福尼亚州门洛帕克--(美国商业资讯)-- Novoloop 作为先进化学回收领域的先驱企业,今日宣布成功完成由Taranis 领投的B轮融资。本轮投资将加速 Novoloop 专有 Lifecycling™ 技术的商业化扩展,该技术可将消费后聚乙烯转化为高性能多元醇和聚氨酯,并支持关键客户项目的启动。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20250624397576/zh-CN/ 此轮...

0评论2025-07-011392

PRD Therapeutics宣布启动PRD001的首例人体研究
东京--(美国商业资讯)-- PRD Therapeutics, Inc.是一家临床阶段公司,专注于开发靶向纯合子家族性高胆固醇血症(HoFH)和代谢功能障碍相关脂肪性肝病(MASH/MASLD)的新型脂质代谢调节剂。该公司今日宣布,近期已启动PRD001的首例人体(FIH)临床试验给药。PRD001是一款同类首创的SOAT2(原称ACAT2)选择性抑制剂。 PRD Therapeutics首席执行官兼联合创始人Kanji Hosoda博士表示:“我们很高兴启动PRD001临...

0评论2025-07-011955

Altimetrik与SLK Software强强联合,打造以AI为核心的工程服务巨头
底特律--(美国商业资讯)--专注于人工智能、数据和数字工程解决方案的领先企业Altimetrik今日宣布,已与全球科技服务公司SLK Software(简称“SLK”)签署最终协议,正式启动收购程序。SLK专注于提供人工智能、智能自动化及数据分析解决方案。此次收购将进一步强化Altimetrik在端到端数字化赋能服务方面的能力,拓展其全球客户版图,并为公司实现年营收突破10亿美元的目标奠定坚实基础。本交易仍需满足惯常成交条件,预计将于2025 年下半年完成。交易的财...

0评论2025-07-011617

BeOne Medicines在研發日展示開創性腫瘤治療管線
百悅澤、索托克拉和BTK CDAC的資料(包括合併用藥)顯示:產品有望全面滿足各類慢性淋巴細胞白血病(CLL)患者的未盡之需 包括CDK4抑制劑、B7-H4 ADC和新型PRMT5抑制劑在內的乳癌、肺癌和胃腸道癌領域的管線產品新資料振奮人心,將成為展示重點 管線研發正處於令人振奮的關鍵轉捩點,未來18個月內將迎來20項里程碑進展 加州聖卡洛斯--(美國商業資訊)--全球腫瘤治療公司BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 68...

0评论2025-07-011028